TEVA

Teva Pharmaceutical Industries Limited
D

TEVA

21.920
USD
0.22
(0.99%)
مغلق
حجم التداول
436,484
الربح لكل سهم
3
العائد الربحي
-
P/E
-26
حجم السوق
24,836,460,691
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    GILD
    GILD
    0.150
    (0.16%)
    91.790 USD
    GSK
    GSK
    -0.035
    (-0.10%)
    33.430 USD
    LLY
    LLY
    -32.08
    (-4.23%)
    726.07 USD
    M
    MNK
    -0.06490
    (-16.07%)
    0.33900 USD
    MRK
    MRK
    -2.790
    (-2.77%)
    97.940 USD
    NVS
    NVS
    -0.320
    (-0.33%)
    97.530 USD
    PFE
    PFE
    -0.195
    (-0.74%)
    26.305 USD
    P
    PRGO
    -0.010
    (-0.04%)
    23.860 USD
    المزيد
الأخبار
المقالات

العنوان: Teva Pharmaceutical Industries Limited

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: the central nervous system with Copaxone, Ajovy, and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.